Companies / BOC Sciences / Ivuxolimab
BOC Sciences

Ivuxolimab | BOC Sciences

Ivuxolimab is a humanized agonistic IgG2 monoclonal antibody. Ivuxolimab selectively binds to OX40, resulting in proliferation of memory and effector T lymphocytes.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.